Pharmabiz13h
Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab
Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...
Pharmabiz12h
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant: Rockville, Maryland Monday, November 4, 2024, 16:00 Hrs [IST] Ther ...
Pharmabiz10h
NIH study demonstrates long-term benefits of weight-loss surgery in young people
NIH study demonstrates long-term benefits of weight-loss surgery in young people: Bethesda, Maryland Monday, November 4, 2024, 18:00 Hrs [IST] Young people with severe obesity who ...
Pharmabiz11h
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...
Pharmabiz20h
IISc gets Rs. 52.47 crore under Ayurswasthya Yojna for CoE in Ayurveda for diabetes and metabolic disorders
Nandita Vijayasimha, Bengaluru Monday, November 4, 2024, 08:00 Hrs [IST] ...
Pharmabiz13h
BioRestorative Therapies’ ThermoStem metabolic disease programme receives Israeli patent
BioRestorative Therapies’ ThermoStem metabolic disease programme receives Israeli patent: Melville, New York Monday, November 4, 2024, 15:00 Hrs [IST] BioRestorative Therapies, ...
Pharmabiz14h
Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer
Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer: Boston Monday, November 4, 2024, 14:00 Hrs ...
Pharmabiz20h
ICMR invites expression of interest for technology transfer to commercialize monkeypox detection assay
ICMR invites expression of interest for technology transfer to commercialize monkeypox detection assay: Shardul Nautiyal, ...
Pharmabiz20h
Jan Aushadhi Kendras report 43% growth on sales in September
Gireesh Babu, New Delhi Monday, November 4, 2024, 08:00 Hrs [IST] The Jan Aushadhi Kendras (JAKs), under the Departme ...
Pharmabiz19h
19th ICDRA created a concept of harmonisation among all drug regulators all over the world: Dr D Roy
ICDRA created a concept of harmonisation among all drug regulators all over the world: Dr D Roy: Our Bureau, Chennai Monday, November 4, 2024, 09:00 Hrs [IST] Evaluating the ...
Pharmabiz20h
No legal provision for separate licence for pharmaceutical marketers: TN drug controller
No legal provision for separate licence for pharmaceutical marketers: TN drug controller: Peethaambaran Kunnathoor, Chennai Monday, November 4, 2024, 08:00 Hrs [IST] The drug cont ...
Pharmabiz20h
Ayush Ministry amends Rules to mandate renewal of manufacturing & loan license to perpetuity
Ayush Ministry amends Rules to mandate renewal of manufacturing & loan license to perpetuity: Gireesh Babu, New Delhi Monday, November 4, 2024, 08:00 Hrs [IST] The Union Ministry ...